News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
283,636 Results
Type
Article (15088)
Company Profile (299)
Press Release (268243)
Multimedia
Podcasts (81)
Webinars (11)
Section
Business (80098)
Career Advice (178)
Deals (13370)
Drug Delivery (41)
Drug Development (50780)
Employer Resources (32)
FDA (5850)
Job Trends (5223)
News (145536)
Policy (10164)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (931)
Accelerated approval (19)
Adcomms (15)
Allergies (81)
Alliances (21832)
ALS (124)
Alzheimer's disease (1035)
Antibody-drug conjugate (ADC) (243)
Approvals (6042)
Artificial intelligence (265)
Autoimmune disease (110)
Automation (10)
Bankruptcy (106)
Best Places to Work (4612)
BIOSECURE Act (6)
Biosimilars (100)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (45)
Breast cancer (356)
Cancer (3155)
Cardiovascular disease (243)
Career advice (163)
Career pathing (7)
CAR-T (218)
CDC (6)
Cell therapy (568)
Cervical cancer (14)
Clinical research (43725)
Collaboration (1152)
Company closure (2)
Compensation (591)
Complete response letters (40)
COVID-19 (1112)
CRISPR (86)
C-suite (551)
Cystic fibrosis (112)
Data (4354)
Denatured (15)
Depression (93)
Diabetes (257)
Diagnostics (1406)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (10)
Drug discovery (187)
Drug pricing (50)
Drug shortages (3)
Duchenne muscular dystrophy (213)
Earnings (31684)
Editorial (25)
Employer branding (4)
Employer resources (30)
Events (52427)
Executive appointments (622)
FDA (7607)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (987)
Gene editing (183)
Generative AI (23)
Gene therapy (492)
GLP-1 (509)
Government (1180)
Grass and pollen (3)
Guidances (167)
Healthcare (6738)
HIV (19)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (190)
Immuno-oncology (39)
Indications (66)
Infectious disease (1220)
Inflammatory bowel disease (155)
Inflation Reduction Act (10)
Influenza (41)
Intellectual property (166)
Interviews (20)
IPO (7360)
IRA (13)
Job creations (874)
Job search strategy (139)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (245)
Leadership (10)
Legal (1426)
Liver cancer (41)
Longevity (11)
Lung cancer (421)
Lymphoma (249)
Machine learning (25)
Management (7)
Manufacturing (379)
MASH (131)
Medical device (2697)
Medtech (2707)
Mergers & acquisitions (6636)
Metabolic disorders (734)
Multiple sclerosis (102)
NASH (14)
Neurodegenerative disease (230)
Neuropsychiatric disorders (70)
Neuroscience (1958)
Neurotech (1)
NextGen: Class of 2026 (2087)
Non-profit (956)
Now hiring (30)
Obesity (334)
Opinion (131)
Ovarian cancer (131)
Pain (105)
Pancreatic cancer (162)
Parkinson's disease (232)
Partnered (12)
Patents (302)
Patient recruitment (327)
Peanut (43)
People (26745)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15493)
Phase 2 (20309)
Phase 3 (12840)
Pipeline (3261)
Policy (92)
Postmarket research (857)
Preclinical (6544)
Press Release (30)
Prostate cancer (146)
Psychedelics (50)
Radiopharmaceuticals (239)
Rare diseases (650)
Real estate (1454)
Recruiting (12)
Regulatory (9938)
Reports (19)
Research institute (981)
Resumes & cover letters (22)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (183)
Series B (135)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (120)
Sponsored (15)
Startups (2007)
State (1)
Stomach cancer (6)
Supply chain (33)
Tariffs (18)
The Weekly (65)
Vaccines (338)
Venture capital (72)
Weight loss (177)
Women's health (26)
Worklife (2)
Date
Last 7 days (348)
Last 30 days (1213)
Last 365 days (17925)
2026 (1662)
2025 (18231)
2024 (20643)
2023 (22530)
2022 (26962)
2021 (27951)
2020 (23543)
2019 (16486)
2018 (11953)
2017 (13809)
2016 (11958)
2015 (14430)
2014 (10463)
2013 (7547)
2012 (7601)
2011 (7688)
2010 (7472)
Location
Africa (160)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18352)
Australia (3131)
California (7105)
Canada (1846)
China (773)
Colorado (248)
Connecticut (253)
Delaware (235)
Europe (39384)
Florida (908)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (402)
India (35)
Indiana (166)
Iowa (9)
Japan (227)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (750)
Massachusetts (5601)
Michigan (110)
Minnesota (249)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (34)
New Hampshire (21)
New Jersey (1660)
New Mexico (13)
New York (1769)
North Carolina (832)
North Dakota (6)
Northern California (3487)
Ohio (178)
Oklahoma (11)
Oregon (24)
Pennsylvania (1281)
Puerto Rico (9)
Rhode Island (25)
South America (219)
South Carolina (9)
Southern California (2818)
Tennessee (40)
Texas (910)
United States (23462)
Utah (98)
Virginia (138)
Washington D.C. (37)
Washington State (598)
West Virginia (1)
Wisconsin (45)
283,636 Results for "spotlight therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Rare diseases
JPM Day 3: Rare Disease in the Spotlight
2026 is shaping up to be a pivotal year for rare disease drugmakers, with key approvals, filings and readouts lined up for this year.
January 15, 2026
·
5 min read
·
Tristan Manalac
Press Releases
AbbVie Launches Love in Mind™ to Spotlight the Emotional Impact of Migraine on Romantic Relationships
January 29, 2026
·
5 min read
Manufacturing
2025: The Year Trump Pushed Manufacturing Into the Spotlight
A push to reshore some drug production and progress in advanced manufacturing technologies have been prominent trends this year, industry leaders say.
December 23, 2025
·
4 min read
·
Nick Paul Taylor
Press Releases
Outlook Therapeutics to Present at the 2025 EURETINA Innovation Spotlight (EIS)
September 4, 2025
·
1 min read
Press Releases
Tiger BioSciences Spotlights Major Clinical and Scientific Milestones Following Significant 2025 Research Investment
December 30, 2025
·
2 min read
Job Trends
BioSpace
2026 Best Places to Work Spotlights Most Desirable Workplaces
BioSpace
has named 50 life sciences companies to its 2026 Best Places to Work list. AbbVie, Amneal Pharmaceuticals and BridgeBio executives share what makes their organizations special.
November 4, 2025
·
7 min read
·
Angela Gabriel
Insights
From Awareness to Acceleration: Rare Disease Drug Development Enters a Pivotal Era
Investor enthusiasm and evolving FDA pathways are accelerating rare disease drug development, with ultrarare conditions like MPS II moving into the spotlight.
February 4, 2026
·
3 min read
·
Jennifer Smith-Parker
Press Releases
Step Pharma to spotlight work in CTPS2-null solid tumours at 2025 EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics
October 21, 2025
·
3 min read
Cancer
ADC, Bispecifics and Kinase Blockers Steal the Spotlight at ESMO 2025 in Berlin
Pfizer, Merck, AstraZeneca and Bristol Myers Squibb were among the many biopharmas showing off novel cancer modalities at ESMO, with antibody-drug conjugates, bispecific antibodies and kinase inhibitors demonstrating encouraging efficacy and safety for various cancers.
October 22, 2025
·
4 min read
·
Tristan Manalac
Press Releases
Quercis Pharma and The Galien Foundation to Spotlight Sickle Cell Disease at the 2025 Patient Summit
October 22, 2025
·
2 min read
1 of 28,364
Next
